Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PHF8 | Q9UPP1 | 6/20 | 0.46 |
| ▸ | KDM2A | Q9Y2K7 | 6/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | KDM5C | P41229 | 4/20 | 0.46 |
| ▸ | EGLN1 | Q9GZT9 | 4/20 | 0.46 |
| ▸ | KDM6B | O15054 | 2/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.41 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2548314 | 0.87 | CYP1A2 (0.47) | LMNACYP1A2CYP2D6MAPTCYP2C9 | |
| SCHEMBL26315807 | 0.85 | HSD17B10 (0.55) | LMNACYP1A2CYP2D6MAPTCYP2C9 | |
| SCHEMBL31120963 | 0.82 | ALDH1A1 (0.46) | LMNASLC15A2KDM1ACNR2 | |
| SCHEMBL29957485 | 0.81 | KDM1A (0.39) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL10021727 | 0.79 | FAAH (0.50) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL2442181 | 0.79 | PHF8 (0.48) | PHF8KDM2AKDM4EKDM5CEGLN1 | |
| SCHEMBL2705007 | 0.79 | — | — | |
| SCHEMBL13575099 | 0.79 | — | — | |
| SCHEMBL23987762 | 0.78 | TSHR (0.54) | KDM4ELMNAMAPTHSD17B10HTT | |
| SCHEMBL22508727 | 0.78 | TSHR (0.51) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113249112-B | Quantum dot and application thereof | 东友精细化工有限公司 | 2025-02-07 | — | — | CN | disclosed |
| US-11822247-B2 | Material for forming organic film, method for forming organic film, patterning process, and compound | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-11-21 | — | — | US | disclosed |
| US-11822247-B2 | Material for forming organic film, method for forming organic film, patterning process, and compound | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-11-21 | — | — | US | disclosed |
| CN-113248953-B | Photoconversion curable composition, cured film, quantum dot light-emitting diode, and image display device | 东友精细化工有限公司 | 2023-02-21 | — | — | CN | disclosed |
| US-11382919-B2 | Prevention and treatment of viral infections | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2022-07-12 | — | — | US | disclosed |
| US-11382919-B2 | Prevention and treatment of viral infections | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2022-07-12 | — | — | US | disclosed |
| US-20210286266-A1 | MATERIAL FOR FORMING ORGANIC FILM, METHOD FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-09-16 | — | — | US | disclosed |
| CN-113249112-A | Quantum dots and applications thereof | 东友精细化工有限公司 | 2021-08-13 | — | — | CN | disclosed |
| CN-113248953-A | Photoconversion curable composition, cured film, quantum dot light-emitting diode, and image display device | 东友精细化工有限公司 | 2021-08-13 | — | — | CN | disclosed |
| US-20210030887-A1 | NON-NATURAL AMATOXIN-TYPE ANTIBODY CONJUGATE | SYSTIMMUNE, INC. | 2021-02-04 | — | — | US | disclosed |
| US-20140100154-A1 | Prodrugs of Peptide Epoxy Ketone Protease Inhibitors | ONYX THERAPEUTICS, INC. (US) | 2014-04-10 | — | — | US | disclosed |
| EP-2696689-A1 | USE OF SUBSTITUTED DITHIINE-TETRACARBOXIMIDES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2014-02-19 | — | — | EP | disclosed |
| US-20140031208-A1 | Use of substituted dithiine-tetracarboximides for combating phytopathogenic fungi | BASF SE (DE) | 2014-01-30 | — | — | US | disclosed |
| WO-2014011695-A2 | PRODRUGS OF PEPTIDE EPOXY KETONE PROTEASE INHIBITORS | ONYX THERAPEUTICS, INC. (US) | 2014-01-16 | — | — | WO | disclosed |
| CN-103476259-A | Use of substituted dithiine tetracarboximides for combating phytopathogenic fungi | BASF SE | 2013-12-25 | — | — | CN | disclosed |
| WO-2012139987-A1 | USE OF SUBSTITUTED DITHIINE-TETRACARBOXIMIDES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2012-10-18 | — | — | WO | disclosed |
| US-20100136034-A1 | NOVEL MULTIMERIC MOLECULES, A PROCESS FOR PREPARING THE SAME AND THE USE THEREOF FOR MANUFACTURING MEDICINAL DRUGS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-06-03 | — | — | US | disclosed |
| US-20100136034-A1 | NOVEL MULTIMERIC MOLECULES, A PROCESS FOR PREPARING THE SAME AND THE USE THEREOF FOR MANUFACTURING MEDICINAL DRUGS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-06-03 | — | — | US | disclosed |
| US-20100136034-A1 | NOVEL MULTIMERIC MOLECULES, A PROCESS FOR PREPARING THE SAME AND THE USE THEREOF FOR MANUFACTURING MEDICINAL DRUGS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-06-03 | — | — | US | disclosed |
| WO-2008110695-A1 | NOVEL MULTIMERIC MOLECULES, METHOD FOR PREPARING SAME AND USE THEREOF IN THE PREPARATION OF DRUGS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2008-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11382919-B2 | Prevention and treatment of viral infections | SMPD1, PTDSS1, PHOSPHO1 | PHF8 1118/4885KDM2A 4366/4885KDM4E 4037/4885 |
| US-11822247-B2 | Material for forming organic film, method for forming organic film, patterning process, and compound | EPCAM, CDH1, DNMT3L | PHF8 283/4885KDM2A 169/4885KDM4E 104/4885 |
| US-20100136034-A1 | NOVEL MULTIMERIC MOLECULES, A PROCESS FOR PREPARING THE SAME AND THE USE THEREOF FOR MANUFACTURING MEDICINAL DRUGS | TNFRSF1A, TNFRSF9, CD40 | PHF8 4586/4885KDM2A 3933/4885KDM4E 2889/4885 |
| US-20140031208-A1 | Use of substituted dithiine-tetracarboximides for combating phytopathogenic fungi | TST, TXN, DPM1 | PHF8 2828/4885KDM2A 2335/4885KDM4E 2721/4885 |
| US-20140100154-A1 | Prodrugs of Peptide Epoxy Ketone Protease Inhibitors | PREP, VIP, PEPD | PHF8 882/4885KDM2A 684/4885KDM4E 377/4885 |
| US-20210030887-A1 | NON-NATURAL AMATOXIN-TYPE ANTIBODY CONJUGATE | CD47, ANPEP, NGLY1 | PHF8 3806/4885KDM2A 3029/4885KDM4E 4076/4885 |
| US-20210286266-A1 | MATERIAL FOR FORMING ORGANIC FILM, METHOD FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND | EPCAM, CDH1, DNMT3L | PHF8 283/4885KDM2A 169/4885KDM4E 104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.